Cierra N. Sharp

Cierra N. Sharp

May 23, 2016

Group 6 Copy 35
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Is yaupon holly extract an effective and safe way to induce cancer cell death?

    Last year our lab discovered that human leukemia cells treated with yaupon holly leaf extract caused cancer...

    How do sponges influence the availability of nutrients on coral reefs?

    Sponges are nature's filtration systems; they can filter up to 50,000 times their own volume in a day. Changes...

    Backer Badge Funded